Series B14 July 2025€84.0MNuclidium raises €84m in Series B funding to accelerate radiopharmaceutical developmentThe round was led by Kurma Growth Opportunities Fund, Angelini Ventures, Wellington Partners, and Neva SGR.NNuclidium— SwitzerlandKGAVWPKurma Growth Opportunities Fund + 9 others